1)- Jessica D Macdougall, A Wesley Burks, Edwin H Kim. Current Insights into Immunotherapy Approaches for Food Allergy.ImmunoTargets and therapy. 2021, 10: 1-8
3)- Ning Xu, Benjamin Tse, Lu Yang, Tiffany C Y Tang, Michelle Haber, Kenneth Micklethwaite, Alla Dolnikov. Priming Leukemia with 5-Azacytidine Enhances CAR T Cell Therapy.ImmunoTargets and therapy. 2021, 10: 123-140
4)- Fabiola Atzeni, Antonio Carriero, Laura Boccassini, Salvatore D'Angelo. Anti-IL-17 Agents in the Treatment of Axial Spondyloarthritis.ImmunoTargets and therapy. 2021, 10: 141-153
6)- Joshua F E Koenig, Kelly Bruton, Allyssa Phelps, Emily Grydziuszko, Rodrigo Jiménez-Saiz, Manel Jordana. Memory Generation and Re-Activation in Food Allergy.ImmunoTargets and therapy. 2021, 10: 171-184
8)- Hamza Hashmi, Muhammad Husnain, Ali Khan, Saad Z Usmani. CD38-Directed Therapies for Management of Multiple Myeloma.ImmunoTargets and therapy. 2021, 10: 201-211
9)- Fumio Takaiwa. Next-Generation Allergen-Specific Immunotherapy for Japanese Cedar Pollinosis Using Molecular Approaches.ImmunoTargets and therapy. 2021, 10: 213-224
11)- Kaja Kasarello, Dagmara Mirowska-Guzel. Anti-CD52 Therapy for Multiple Sclerosis: An Update in the COVID Era.ImmunoTargets and therapy. 2021, 10: 237-246
13)- Valeria Giorgi, Daniela Marotto, Alberto Batticciotto, Fabiola Atzeni, Sara Bongiovanni, Piercarlo Sarzi-Puttini. Cannabis and Autoimmunity: Possible Mechanisms of Action.ImmunoTargets and therapy. 2021, 10: 261-271
16)- Sarah Unterberger, Kevin A Davies, Srinivasa Bhargav Rambhatla, Sandra Sacre. Contribution of Toll-Like Receptors and the NLRP3 Inflammasome in Rheumatoid Arthritis Pathophysiology.ImmunoTargets and therapy. 2021, 10: 285-298
19)- Michael Levy, Maureen A Mealy. B-Cell Targeted Treatments for Neuromyelitis Optica Spectrum Disorder: A Focus on CD19 and CD20.ImmunoTargets and therapy. 2021, 10: 325-331
20)- Laura C Arneson, Kristen J Carroll, Eric M Ruderman. Bruton's Tyrosine Kinase Inhibition for the Treatment of Rheumatoid Arthritis.ImmunoTargets and therapy. 2021, 10: 333-342
22)- Angela Gomez-Arboledas, Munjal M Acharya, Andrea J Tenner. The Role of Complement in Synaptic Pruning and Neurodegeneration.ImmunoTargets and therapy. 2021, 10: 373-386
23)- Surojit Karmakar, Pradipta Pal, Girdhari Lal. Key Activating and Inhibitory Ligands Involved in the Mobilization of Natural Killer Cells for Cancer Immunotherapies.ImmunoTargets and therapy. 2021, 10: 387-407
24)- Megan Mosca, Julie Hong, Edward Hadeler, Marwa Hakimi, Wilson Liao, Tina Bhutani. The Role of IL-17 Cytokines in Psoriasis.ImmunoTargets and therapy. 2021, 10: 409-418
25)- Bárbara Kong-Cardoso, Amélia Ribeiro, Rita Aguiar, Helena Pité, Mário Morais-Almeida. Understanding and Managing Severe Asthma in the Context of COVID-19.ImmunoTargets and therapy. 2021, 10: 419-430
26)- Shouling Zhang, Scott Sicherer, M Cecilia Berin, Amanda Agyemang. Pathophysiology of Non-IgE-Mediated Food Allergy.ImmunoTargets and therapy. 2021, 10: 431-446
27)- Priscila O Barros, Tamara K Berthoud, Nawaf Aloufi, Jonathan B Angel. Soluble IL-7Rα/sCD127 in Health, Disease, and Its Potential Role as a Therapeutic Agent.ImmunoTargets and therapy. 2021, 10: 47-62
29)- Friederike Held, Ana-Katharina Klein, Achim Berthele. Drug Treatment of Neuromyelitis Optica Spectrum Disorders: Out with the Old, in with the New?ImmunoTargets and therapy. 2021, 10: 87-101
30)- Francesco Passiglia, Maria Lucia Reale, Valeria Cetoretta, Silvia Novello. Immune-Checkpoint Inhibitors Combinations in Metastatic NSCLC: New Options on the Horizon?ImmunoTargets and therapy. 2021, 10: 9-26